Skip to main content
letter
. 2022 Jul 1;85(4):436–480. doi: 10.1016/j.jinf.2022.06.027

Fig. 1.

Fig 1

(A) Association between mAbs treatment and mortality (B) Association between mAbs treatment and developing severe COVID-19.